See All Slides - tctmd.com

Slides

Presentation

One-Year Outcomes of FFRCT-Guided Care in Patients With Suspected CAD

Presenter: Pamela Douglas

July 26, 2016

Presentation JIM 2016

Manli Mirage :A Bioresorbable Microfiber scaffold

Presenter: Tegu Santoso

February 10, 2016

Presentation TVT 2016

Harpoon: Minimizing Access for Transapical Chordal Replacement

Presenter: Neil E. Moat

June 17, 2016

Presentation TVT 2016

TVT 1063: What Is the Optimal Treatment for Residual Commissural Jet Following MitraClip? Ventricular Septal Defect Occluder Device vs Gore CARDIOFORM

Presenter: Yoshifumi Nakajima, MD

June 16, 2016

Presentation TVT 2016

Three Interesting TAVR Valve-in-Valve Cases

Presenter: Isaac George

June 17, 2016

Presentation

Three-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter AVR

Presenter: G. Michael Deeb

April 06, 2016

Presentation EuroPCR 2016

First Look at Long-term Durability of Transcatheter Heart Valves: Assessment of Valve Function up To 10-years After Implantation

Presenter: Danny Dvir

May 19, 2016

Presentation

Outcomes with Bioresorbable Vascular Scaffolds versus Everolimus-Eluting Stent

Presenter: Sripal Bangalore

March 29, 2016

Presentation

PCI for Stenoses in Small Coronary Arteries

Presenter: George Siontis

June 16, 2016

Presentation JIM 2016

Clinical Case: High risk ACS

Presenter: Giuseppe Tarantini

February 11, 2016

Advertisement

Slides

One-Year Outcomes of FFRCT-Guided Care in Patients With Suspected CAD

Manli Mirage :A Bioresorbable Microfiber scaffold

Harpoon: Minimizing Access for Transapical Chordal Replacement

TVT 1063: What Is the Optimal Treatment for Residual Commissural Jet Following MitraClip? Ventricular Septal Defect Occluder Device vs Gore CARDIOFORM

Three Interesting TAVR Valve-in-Valve Cases

Three-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter AVR

First Look at Long-term Durability of Transcatheter Heart Valves: Assessment of Valve Function up To 10-years After Implantation

Outcomes with Bioresorbable Vascular Scaffolds versus Everolimus-Eluting Stent

PCI for Stenoses in Small Coronary Arteries

Clinical Case: High risk ACS

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content